Xenova’s cocaine vaccine shows promise
June 15, 2004Cocaine addicts could be helped by a vaccine currently in development by UK biotech company Xenova, phase II results from …
Abbott buys heart drug from Aventis for $300 million
June 10, 2004Chicago-based Abbott Laboratories has bought the marketing and manufacturing rights for cardiovascular drug trandolapril from Aventis, in a deal worth …
New schizophrenia drug Abilify gets European go-ahead
June 10, 2004Abilify, Bristol-Myers Squibb and Otsuka's antipsychotic has received European Union marketing approval and will be promoted for having fewer side …
Lipitor halves stroke risk in diabetes patients
June 8, 2004New Lipitor data suggests the drug cut the risk of stroke by half in diabetes patients, the compelling evidence potentially …
Shire relocates R&D headquarters to US
June 3, 2004Shire Pharmaceuticals has relocated its research and development headquarters to the US as the company looks to increase its penetration …
Oxford BioMedica one step closer to Holy Grail of nerve damage
June 3, 2004The promise of a gene-based technology which might one day cure spinal injuries and paralysis has moved one step closer …
PCT claims bullying over private contract
June 3, 2004An NHS trust chairman has accused the government of bullying it into awarding a contract to a private firm, resulting …
Unmet needs in arthritis
June 3, 2004Although there is no cure for rheumatoid arthritis (RA), a wide range of drugs are involved in its treatment. Similar …
CROs: flexible or overstretched?
June 3, 2004If only I had known then what I know now about the labyrinthine world of Contract Research Organisations (CROs). This …
Counterfeit medicines on the rise
June 1, 2004The World Health Organisation (WHO) estimates that up to 10% of medicines worldwide may be counterfeit, costing the pharmaceutical industry …
Making the most of your talent
May 27, 2004The vast majority of pharma executives would argue that having a large number of products in any company's portfolio should …
Roche prescribing data to support NICE uptake
May 27, 2004Roche is to provide NICE with regular updates on patient access to its treatments to help increase the uptake of …
NICE strikes deal with industry on data confidentiality
May 26, 2004The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
